Toshiyuki Takemori
Overview
Explore the profile of Toshiyuki Takemori including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
98
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Toda Y, Ogura K, Morizane C, Satake T, Iwata S, Kobayashi E, et al.
Int J Clin Oncol
. 2025 Feb;
PMID: 39988636
Background: In aging societies like Japan, the number of elderly bone sarcoma (BS) and soft-tissue sarcoma (STS) patients is increasing. However, these malignancies' behavior is incompletely understood. We investigated clinical...
2.
Iwata S, Noguchi R, Oosaki J, Adachi Y, Shiota Y, Kobayashi E, et al.
Hum Cell
. 2025 Feb;
38(2):49.
PMID: 39904835
Solitary fibrous tumors (SFTs) are rare mesenchymal tumors characterized by recurrent NAB2::STAT6 gene fusion, which are associated with an unpredictable clinical course, including the potential for recurrence or metastasis. Current...
3.
Kondo H, Ogura K, Morizane C, Satake T, Iwata S, Toda Y, et al.
Jpn J Clin Oncol
. 2025 Feb;
PMID: 39893587
Background: Chondrosarcoma (CS) is a rare malignant bone tumor exhibiting diverse histological features and clinical behaviors. This study aimed to investigate the epidemiological characteristics, clinical features, prognostic factors, and subtype-specific...
4.
Miyamoto T, Fukase N, Kawamoto T, Fujiwara S, Hara H, Sawada R, et al.
Oncol Rep
. 2024 Dec;
53(2).
PMID: 39704263
Cancer stem cells (CSCs) have been implicated as critical mediators in the progression, chemoresistance and metastatic capabilities of diverse malignancies, including osteosarcoma (OS). The authors have succeeded in generating CSC‑like...
5.
Takemori T, Ogura K, Morizane C, Satake T, Iwata S, Toda Y, et al.
Jpn J Clin Oncol
. 2024 Aug;
54(12):1281-1287.
PMID: 39196756
Background: Clear cell sarcoma is rare, so no reports have previously characterized its national profiles. We examined the nationwide epidemiology and clinical outcomes of patients with clear cell sarcoma based...
6.
Ogura K, Morizane C, Satake T, Iwata S, Toda Y, Muramatsu S, et al.
Jpn J Clin Oncol
. 2024 Jul;
54(11):1150-1157.
PMID: 38970830
Background: No previous reports have characterized national profiles of soft-tissue sarcoma overall. We examined the nationwide statistics for soft-tissue sarcoma in Japan using data from the population-based National Cancer Registry....
7.
Takemori T, Hara H, Kawamoto T, Fukase N, Sawada R, Fujiwara S, et al.
J Orthop Sci
. 2024 Jul;
PMID: 38964957
Background: Few studies have compared the clinical outcomes of patients with pelvic bone sarcomas treated surgically and those treated with particle beam therapy. This is a multicenter retrospective cohort study...
8.
Yahiro S, Kawamoto T, Fujiwara S, Hara H, Fukase N, Sawada R, et al.
Int J Oncol
. 2022 Sep;
61(5).
PMID: 36148888
Ewing sarcoma (ES) is an aggressive primary malignant bone tumor that predominantly affects children and young adults. Multimodal treatment approaches have markedly improved the survival of patients with localized ES....
9.
Takemori T, Kawamoto T, Hara H, Fukase N, Fujiwara S, Fujita I, et al.
Cancers (Basel)
. 2022 Jun;
14(12).
PMID: 35740688
This study aimed to retrospectively analyze the clinical outcomes of patients with pelvic and retroperitoneal bone and soft tissue sarcoma (BSTS). Overall, 187 patients with BSTS in the pelvis and...
10.
Takemori T, Kawamoto T, Hara H, Fukase N, Fujiwara S, Kitayama K, et al.
Cancer Manag Res
. 2022 Jun;
14:1815-1824.
PMID: 35642242
Purpose: Soft tissue sarcomas (STSs) constitute a group of rare, heterogeneous tumors representing approximately 1% of all cancers. Owing to the rarity and pathological diversity of the disease, unplanned excision...